Corinth MedTech, Inc.
Corinth MedTech develops, manufactures and markets urological device solutions that address unmet needs in an innovative, cost- effective manner. The company`s lead product, The Veloxion System, featuring Velo360 Technology, is FDA cleared for use in treating the symptoms of Benign Prostatic Hyperplasia (BPH) and Bladder Tumors, conditions affecting millions of people worldwide. It has the unique distinction of featuring a first-of-its-kind single-use resectoscope for TURP. Corinth MedTech, Inc., was founded in 2014 by pioneering visionary Csaba Truckai, renowned for his device innovation in gynecology and urology; it is estimated his products are being used in over 2,000 surgeries each day worldwide.
Headquartered in San Jose, CA, the company is backed by leading investors in healthcare technology and on their way to commercialization. Currently the company is conducting limited pre-market evaluations in the United States in preparation for their planned commercialization launch later this year.
The company is initially focused on TURP procedures with development efforts underway for advancements in the TURBT application.